Published in Endocrine on April 03, 2017
Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis. Osteoporos Int (2006) 5.50
Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab (2001) 4.03
Bone density in non-insulin-dependent diabetes mellitus. The Rotterdam Study. Ann Intern Med (1995) 2.70
Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int (2010) 2.69
Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science (1997) 2.31
Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group. Diabetes Care (1996) 2.11
Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. J Clin Invest (1986) 2.02
Specific binding of proinsulin C-peptide to human cell membranes. Proc Natl Acad Sci U S A (1999) 1.91
Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes. N Engl J Med (1976) 1.66
Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus. Diabet Med (2000) 1.63
The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med (2013) 1.50
The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia (1992) 1.47
Role of C-peptide in human physiology. Am J Physiol Endocrinol Metab (2000) 1.44
Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetes. Bone (2009) 1.35
Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J Clin Endocrinol Metab (1993) 1.29
Bone mineral loss in insulin-treated diabetes mellitus: studies on pathogenesis. Acta Endocrinol (Copenh) (1979) 1.28
Assays for insulin, proinsulin(s) and C-peptide. Ann Clin Biochem (1999) 1.23
Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients. Diabetologia (1992) 1.22
Residual insulin production, glycaemic control and prevalence of microvascular lesions and polyneuropathy in long-term type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1987) 1.18
The effects of lifestyle, dietary dairy intake and diabetes on bone density and vertebral deformity prevalence: the EVOS study. Osteoporos Int (2001) 1.17
Impact of C-peptide preservation on metabolic and clinical outcomes in the Diabetes Control and Complications Trial. Diabetes (2013) 1.11
Decreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent diabetes mellitus followed longitudinally. J Pediatr Endocrinol Metab (1998) 1.09
Effects of C-peptide on renal function at the early stage of experimental diabetes. Kidney Int (1998) 1.09
Sex differences in osteoporosis in older adults with non-insulin-dependent diabetes mellitus. JAMA (1992) 1.07
Differential effects of proinsulin C-peptide fragments on Na+, K+-ATPase activity of renal tubule segments. Diabetologia (1998) 1.07
C-peptide improves autonomic nerve function in IDDM patients. Diabetologia (1996) 1.06
C-peptide stimulates Na+, K+-ATPase via activation of ERK1/2 MAP kinases in human renal tubular cells. Cell Mol Life Sci (2004) 1.04
Amelioration of sensory nerve dysfunction by C-Peptide in patients with type 1 diabetes. Diabetes (2003) 1.02
Isolation of a proinsulin connecting peptide fragment (C-peptide) from bovine and human pancreas. Biochem Biophys Res Commun (1969) 0.98
Complications of diabetes. Prevalence, detection, current treatment, and prognosis. Am J Med (1985) 0.93
Osteoporosis in chronic inflammatory disease: the role of malnutrition. Endocrine (2012) 0.93
Proinsulin C-peptide activates cAMP response element-binding proteins through the p38 mitogen-activated protein kinase pathway in mouse lung capillary endothelial cells. Biochem J (2002) 0.92
Bone mineral density at time of clinical diagnosis of adult-onset type 1 diabetes mellitus. Endocr Pract (2001) 0.90
Proinsulin C-peptide abrogates type-1 diabetes-induced increase of renal endothelial nitric oxide synthase in rats. Diabetes Metab Res Rev (2008) 0.89
Potent activation of multiple signalling pathways by C-peptide in opossum kidney proximal tubular cells. Diabetologia (2004) 0.89
High prevalence of proliferative retinopathy in diabetic patients with low pancreatic B-cell capacity. Diabetes Res Clin Pract (1989) 0.88
Proceedings: Bone mineral determinations on long-term diabetics. AJR Am J Roentgenol (1976) 0.87
The relevance of persistent C-peptide secretion in type 1 (insulin-dependent) diabetes mellitus to glycaemic control and diabetic complications. Diabetes Res Clin Pract (1990) 0.83
C-peptide improves neuropathy in type 1 diabetic BB/Wor-rats. Diabetes Metab Res Rev (2007) 0.83
Decreased cortical thickness & osteopenia in children with diabetes mellitus. J Clin Endocrinol Metab (1977) 0.81
Demonstration of an intrinsic relationship between endogenous C-peptide concentration and determinants of glycemic control in type 1 diabetes following islet transplantation. Diabetes Care (2014) 0.78
Proinsulin C-peptide prevents type-1 diabetes-induced decrease of renal Na+-K+-ATPase alpha1-subunit in rats. Diabetes Metab Res Rev (2010) 0.78
Long-Acting C-Peptide and Neuropathy in Type 1 Diabetes: A 12-Month Clinical Trial. Diabetes Care (2016) 0.78
The association between the serum C-peptide level and bone mineral density. PLoS One (2013) 0.77
Association between low C-peptide and low lumbar bone mineral density in postmenopausal women without diabetes. Osteoporos Int (2015) 0.77
Proinsulin C-peptide modulates the expression of ERK1/2, type I collagen and RANKL in human osteoblast-like cells (Saos-2). Mol Cell Endocrinol (2016) 0.77
Alterations of bone and mineral metabolism in diabetes mellitus. Part I. An overview. S Afr Med J (1987) 0.76
Different health behaviours and clinical factors associated with bone mineral density and bone turnover in premenopausal women with and without type 1 diabetes. Diabetes Metab Res Rev (2015) 0.76